 | • レポートコード：GIR-23F3745 • 出版社/出版日：GlobalInfoResearch / 2023年2月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Antacids Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の制酸剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 制酸剤市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・非全身性制酸剤、全身性制酸剤 アプリケーション別セグメントは次のように区分されます。 ・Rx医薬品、OTC医薬品 世界の制酸剤市場の主要なマーケットプレーヤーは以下のとおりです。 ・AstraZeneca、Takeda Pharmaceutical、Pfizer、Reckitt Benckiser、Bayer、Procter & Gamble、GlaxoSmithKline、Johnson & Johnson、CONBA、Xiuzheng Pharma、Sanofi、Bausch Health、CR SANJIU、Novartis 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 制酸剤の概要 - タイプ別分析（2017年vs2021年vs2028年）：非全身性制酸剤、全身性制酸剤 - アプリケーション別分析（2017年vs2021年vs2028年）：Rx医薬品、OTC医薬品 - 世界の制酸剤市場規模・予測 - 世界の制酸剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - AstraZeneca、Takeda Pharmaceutical、Pfizer、Reckitt Benckiser、Bayer、Procter & Gamble、GlaxoSmithKline、Johnson & Johnson、CONBA、Xiuzheng Pharma、Sanofi、Bausch Health、CR SANJIU、Novartis ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：非全身性制酸剤、全身性制酸剤 ・アプリケーション別分析2017年-2028年：Rx医薬品、OTC医薬品 ・制酸剤の北米市場分析 - 制酸剤の北米市場：タイプ別市場規模2017年-2028年 - 制酸剤の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・制酸剤のヨーロッパ市場分析 - ：制酸剤のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：制酸剤のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・制酸剤のアジア太平洋市場分析 - 制酸剤のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 制酸剤のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・制酸剤の南米市場分析 - 制酸剤の南米市場：タイプ別市場規模2017年-2028年 - 制酸剤の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・制酸剤の中東・アフリカ市場分析 - 制酸剤の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 制酸剤の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antacids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antacids market size is estimated to be worth US$ 6112 million in 2021 and is forecast to a readjusted size of USD 7169.7 million by 2028 with a CAGR of 2.3% during review period. Rx Drug accounting for % of the Antacids global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Non-Systemic Antacids segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antacids include AstraZeneca, Takeda Pharmaceutical, Pfizer, Reckitt Benckiser, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antacids market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Non-Systemic Antacids
Systemic Antacids
Market segment by Application can be divided into
Rx Drug
OTC Drug
The key market players for global Antacids market are listed below:
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter & Gamble
GlaxoSmithKline
Johnson & Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antacids product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antacids, with price, sales, revenue and global market share of Antacids from 2019 to 2022.
Chapter 3, the Antacids competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antacids breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antacids market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antacids.
Chapter 13, 14, and 15, to describe Antacids sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Antacids Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antacids Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Non-Systemic Antacids
1.2.3 Systemic Antacids
1.3 Market Analysis by Application
1.3.1 Overview: Global Antacids Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Rx Drug
1.3.3 OTC Drug
1.4 Global Antacids Market Size & Forecast
1.4.1 Global Antacids Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antacids Sales in Volume (2017-2028)
1.4.3 Global Antacids Price (2017-2028)
1.5 Global Antacids Production Capacity Analysis
1.5.1 Global Antacids Total Production Capacity (2017-2028)
1.5.2 Global Antacids Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antacids Market Drivers
1.6.2 Antacids Market Restraints
1.6.3 Antacids Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Antacids Product and Services
2.1.4 AstraZeneca Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Takeda Pharmaceutical
2.2.1 Takeda Pharmaceutical Details
2.2.2 Takeda Pharmaceutical Major Business
2.2.3 Takeda Pharmaceutical Antacids Product and Services
2.2.4 Takeda Pharmaceutical Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Antacids Product and Services
2.3.4 Pfizer Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Reckitt Benckiser
2.4.1 Reckitt Benckiser Details
2.4.2 Reckitt Benckiser Major Business
2.4.3 Reckitt Benckiser Antacids Product and Services
2.4.4 Reckitt Benckiser Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Antacids Product and Services
2.5.4 Bayer Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Procter & Gamble
2.6.1 Procter & Gamble Details
2.6.2 Procter & Gamble Major Business
2.6.3 Procter & Gamble Antacids Product and Services
2.6.4 Procter & Gamble Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Antacids Product and Services
2.7.4 GlaxoSmithKline Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Antacids Product and Services
2.8.4 Johnson & Johnson Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 CONBA
2.9.1 CONBA Details
2.9.2 CONBA Major Business
2.9.3 CONBA Antacids Product and Services
2.9.4 CONBA Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Xiuzheng Pharma
2.10.1 Xiuzheng Pharma Details
2.10.2 Xiuzheng Pharma Major Business
2.10.3 Xiuzheng Pharma Antacids Product and Services
2.10.4 Xiuzheng Pharma Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business
2.11.3 Sanofi Antacids Product and Services
2.11.4 Sanofi Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Bausch Health
2.12.1 Bausch Health Details
2.12.2 Bausch Health Major Business
2.12.3 Bausch Health Antacids Product and Services
2.12.4 Bausch Health Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 CR SANJIU
2.13.1 CR SANJIU Details
2.13.2 CR SANJIU Major Business
2.13.3 CR SANJIU Antacids Product and Services
2.13.4 CR SANJIU Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Novartis
2.14.1 Novartis Details
2.14.2 Novartis Major Business
2.14.3 Novartis Antacids Product and Services
2.14.4 Novartis Antacids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antacids Breakdown Data by Manufacturer
3.1 Global Antacids Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antacids Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antacids
3.4 Market Concentration Rate
3.4.1 Top 3 Antacids Manufacturer Market Share in 2021
3.4.2 Top 6 Antacids Manufacturer Market Share in 2021
3.5 Global Antacids Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antacids Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antacids Market Size by Region
4.1.1 Global Antacids Sales in Volume by Region (2017-2028)
4.1.2 Global Antacids Revenue by Region (2017-2028)
4.2 North America Antacids Revenue (2017-2028)
4.3 Europe Antacids Revenue (2017-2028)
4.4 Asia-Pacific Antacids Revenue (2017-2028)
4.5 South America Antacids Revenue (2017-2028)
4.6 Middle East and Africa Antacids Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antacids Sales in Volume by Type (2017-2028)
5.2 Global Antacids Revenue by Type (2017-2028)
5.3 Global Antacids Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antacids Sales in Volume by Application (2017-2028)
6.2 Global Antacids Revenue by Application (2017-2028)
6.3 Global Antacids Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antacids Sales by Type (2017-2028)
7.2 North America Antacids Sales by Application (2017-2028)
7.3 North America Antacids Market Size by Country
7.3.1 North America Antacids Sales in Volume by Country (2017-2028)
7.3.2 North America Antacids Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antacids Sales by Type (2017-2028)
8.2 Europe Antacids Sales by Application (2017-2028)
8.3 Europe Antacids Market Size by Country
8.3.1 Europe Antacids Sales in Volume by Country (2017-2028)
8.3.2 Europe Antacids Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antacids Sales by Type (2017-2028)
9.2 Asia-Pacific Antacids Sales by Application (2017-2028)
9.3 Asia-Pacific Antacids Market Size by Region
9.3.1 Asia-Pacific Antacids Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antacids Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antacids Sales by Type (2017-2028)
10.2 South America Antacids Sales by Application (2017-2028)
10.3 South America Antacids Market Size by Country
10.3.1 South America Antacids Sales in Volume by Country (2017-2028)
10.3.2 South America Antacids Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antacids Sales by Type (2017-2028)
11.2 Middle East & Africa Antacids Sales by Application (2017-2028)
11.3 Middle East & Africa Antacids Market Size by Country
11.3.1 Middle East & Africa Antacids Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antacids Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antacids and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antacids
12.3 Antacids Production Process
12.4 Antacids Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antacids Typical Distributors
13.3 Antacids Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Antacids Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antacids Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Antacids Product and Services
Table 6. AstraZeneca Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Takeda Pharmaceutical Major Business
Table 9. Takeda Pharmaceutical Antacids Product and Services
Table 10. Takeda Pharmaceutical Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Antacids Product and Services
Table 14. Pfizer Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Reckitt Benckiser Basic Information, Manufacturing Base and Competitors
Table 16. Reckitt Benckiser Major Business
Table 17. Reckitt Benckiser Antacids Product and Services
Table 18. Reckitt Benckiser Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Antacids Product and Services
Table 22. Bayer Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Procter & Gamble Basic Information, Manufacturing Base and Competitors
Table 24. Procter & Gamble Major Business
Table 25. Procter & Gamble Antacids Product and Services
Table 26. Procter & Gamble Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 28. GlaxoSmithKline Major Business
Table 29. GlaxoSmithKline Antacids Product and Services
Table 30. GlaxoSmithKline Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 32. Johnson & Johnson Major Business
Table 33. Johnson & Johnson Antacids Product and Services
Table 34. Johnson & Johnson Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. CONBA Basic Information, Manufacturing Base and Competitors
Table 36. CONBA Major Business
Table 37. CONBA Antacids Product and Services
Table 38. CONBA Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Xiuzheng Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Xiuzheng Pharma Major Business
Table 41. Xiuzheng Pharma Antacids Product and Services
Table 42. Xiuzheng Pharma Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Sanofi Basic Information, Manufacturing Base and Competitors
Table 44. Sanofi Major Business
Table 45. Sanofi Antacids Product and Services
Table 46. Sanofi Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 48. Bausch Health Major Business
Table 49. Bausch Health Antacids Product and Services
Table 50. Bausch Health Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. CR SANJIU Basic Information, Manufacturing Base and Competitors
Table 52. CR SANJIU Major Business
Table 53. CR SANJIU Antacids Product and Services
Table 54. CR SANJIU Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Novartis Basic Information, Manufacturing Base and Competitors
Table 56. Novartis Major Business
Table 57. Novartis Antacids Product and Services
Table 58. Novartis Antacids Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Antacids Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Antacids Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Antacids, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Antacids Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Antacids Production Site of Key Manufacturer
Table 64. Antacids New Entrant and Capacity Expansion Plans
Table 65. Antacids Mergers & Acquisitions in the Past Five Years
Table 66. Global Antacids Sales by Region (2017-2022) & (K Units)
Table 67. Global Antacids Sales by Region (2023-2028) & (K Units)
Table 68. Global Antacids Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Antacids Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Antacids Sales by Type (2017-2022) & (K Units)
Table 71. Global Antacids Sales by Type (2023-2028) & (K Units)
Table 72. Global Antacids Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Antacids Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Antacids Price by Type (2017-2022) & (US$/Unit)
Table 75. Global Antacids Price by Type (2023-2028) & (US$/Unit)
Table 76. Global Antacids Sales by Application (2017-2022) & (K Units)
Table 77. Global Antacids Sales by Application (2023-2028) & (K Units)
Table 78. Global Antacids Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Antacids Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Antacids Price by Application (2017-2022) & (US$/Unit)
Table 81. Global Antacids Price by Application (2023-2028) & (US$/Unit)
Table 82. North America Antacids Sales by Country (2017-2022) & (K Units)
Table 83. North America Antacids Sales by Country (2023-2028) & (K Units)
Table 84. North America Antacids Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Antacids Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Antacids Sales by Type (2017-2022) & (K Units)
Table 87. North America Antacids Sales by Type (2023-2028) & (K Units)
Table 88. North America Antacids Sales by Application (2017-2022) & (K Units)
Table 89. North America Antacids Sales by Application (2023-2028) & (K Units)
Table 90. Europe Antacids Sales by Country (2017-2022) & (K Units)
Table 91. Europe Antacids Sales by Country (2023-2028) & (K Units)
Table 92. Europe Antacids Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Antacids Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Antacids Sales by Type (2017-2022) & (K Units)
Table 95. Europe Antacids Sales by Type (2023-2028) & (K Units)
Table 96. Europe Antacids Sales by Application (2017-2022) & (K Units)
Table 97. Europe Antacids Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Antacids Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Antacids Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Antacids Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Antacids Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Antacids Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Antacids Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Antacids Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Antacids Sales by Application (2023-2028) & (K Units)
Table 106. South America Antacids Sales by Country (2017-2022) & (K Units)
Table 107. South America Antacids Sales by Country (2023-2028) & (K Units)
Table 108. South America Antacids Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Antacids Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Antacids Sales by Type (2017-2022) & (K Units)
Table 111. South America Antacids Sales by Type (2023-2028) & (K Units)
Table 112. South America Antacids Sales by Application (2017-2022) & (K Units)
Table 113. South America Antacids Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Antacids Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Antacids Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Antacids Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Antacids Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Antacids Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Antacids Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Antacids Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Antacids Sales by Application (2023-2028) & (K Units)
Table 122. Antacids Raw Material
Table 123. Key Manufacturers of Antacids Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Antacids Typical Distributors
Table 127. Antacids Typical Customers
List of Figures
Figure 1. Antacids Picture
Figure 2. Global Antacids Revenue Market Share by Type in 2021
Figure 3. Non-Systemic Antacids
Figure 4. Systemic Antacids
Figure 5. Global Antacids Revenue Market Share by Application in 2021
Figure 6. Rx Drug
Figure 7. OTC Drug
Figure 8. Global Antacids Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Antacids Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Antacids Sales (2017-2028) & (K Units)
Figure 11. Global Antacids Price (2017-2028) & (US$/Unit)
Figure 12. Global Antacids Production Capacity (2017-2028) & (K Units)
Figure 13. Global Antacids Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Antacids Market Drivers
Figure 15. Antacids Market Restraints
Figure 16. Antacids Market Trends
Figure 17. Global Antacids Sales Market Share by Manufacturer in 2021
Figure 18. Global Antacids Revenue Market Share by Manufacturer in 2021
Figure 19. Antacids Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Antacids Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Antacids Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Antacids Sales Market Share by Region (2017-2028)
Figure 23. Global Antacids Revenue Market Share by Region (2017-2028)
Figure 24. North America Antacids Revenue (2017-2028) & (USD Million)
Figure 25. Europe Antacids Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Antacids Revenue (2017-2028) & (USD Million)
Figure 27. South America Antacids Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Antacids Revenue (2017-2028) & (USD Million)
Figure 29. Global Antacids Sales Market Share by Type (2017-2028)
Figure 30. Global Antacids Revenue Market Share by Type (2017-2028)
Figure 31. Global Antacids Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Antacids Sales Market Share by Application (2017-2028)
Figure 33. Global Antacids Revenue Market Share by Application (2017-2028)
Figure 34. Global Antacids Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Antacids Sales Market Share by Type (2017-2028)
Figure 36. North America Antacids Sales Market Share by Application (2017-2028)
Figure 37. North America Antacids Sales Market Share by Country (2017-2028)
Figure 38. North America Antacids Revenue Market Share by Country (2017-2028)
Figure 39. United States Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Antacids Sales Market Share by Type (2017-2028)
Figure 43. Europe Antacids Sales Market Share by Application (2017-2028)
Figure 44. Europe Antacids Sales Market Share by Country (2017-2028)
Figure 45. Europe Antacids Revenue Market Share by Country (2017-2028)
Figure 46. Germany Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Antacids Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Antacids Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Antacids Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Antacids Revenue Market Share by Region (2017-2028)
Figure 55. China Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Antacids Sales Market Share by Type (2017-2028)
Figure 62. South America Antacids Sales Market Share by Application (2017-2028)
Figure 63. South America Antacids Sales Market Share by Country (2017-2028)
Figure 64. South America Antacids Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Antacids Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Antacids Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Antacids Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Antacids Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Antacids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Antacids in 2021
Figure 76. Manufacturing Process Analysis of Antacids
Figure 77. Antacids Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
| 【制酸剤について】 制酸剤（Antacids）は、主に胃酸を中和する目的で使用される医薬品の一種です。胃酸の過剰分泌や胃酸による痛み、逆流性食道炎などの症状を軽減するために用いられます。制酸剤は、一般的には即効性があり、胃の不快感を迅速に和らげることができるため、多くの人々にとって日常的に利用される重要な医薬品となっています。 制酸剤の基本的な定義は、胃酸（主に塩酸）を中和する作用を持つ物質であり、通常は水溶性のアルカリ土類金属塩や無機塩類が含まれています。これらの成分が胃酸と反応し、酸を中和してpHを上昇させ、痛みや不快感を軽減します。 制酸剤の特徴としては、まずその即効性が挙げられます。食後や胃の不快感を感じた際に服用することで、数分で効果が現れることがほとんどです。また、制酸剤は比較的副作用が少なく、広範に使用されていますが、過剰に使用することで電解質のバランスが崩れたり、腎機能に影響を及ぼす可能性があるため、使用には注意が必要です。さらに、長期間の使用は推奨されず、これが慢性的な胃症状を隠す原因となることもあります。 制酸剤にはさまざまな種類があり、主に無機化合物が基礎となっています。一般的な制酸剤に含まれる成分は次の通りです。 1. **水酸化アルミニウム**：胃酸を中和する作用があり、便秘を引き起こすことから、しばしばマグネシウムと併用されます。即効性があり、効能も持続します。 2. **水酸化マグネシウム**：この成分も胃酸を中和し、腸の運動を刺激するため、便秘の緩和に寄与します。ただし、大量に摂取すると下痢を引き起こすことがあります。 3. **炭酸水素ナトリウム**：非常に速い効果があり、食道逆流症の治療にも効果的ですが、ナトリウムを多く含むため、高血圧の患者には注意が必要です。 4. **炭酸カルシウム**：比較的速やかに効果が現れ、カルシウム補給にもつながるため、特に女性や高齢者にとって有用です。ただし、使用を続けることで腎結石を含む副作用が生じることがあります。 これらの制酸剤は、一部はOTC（一般用医薬品）として薬局やスーパーで販売されており、誰でも容易に入手することができます。制酸剤は、過剰な酸を中和することで得られる直接的な効果に加え、酸に起因する不快感を改善するため、様々な胃の不調に対して幅広く用いられています。 制酸剤の用途は多岐にわたりますが、主に以下のような症状の緩和に使用されます。 - **消化不良**：食後、特に脂肪分の多い食事を摂った後などに胃がもたつくことがありますが、その症状を軽減するために制酸剤が使用されることがあります。 - **逆流性食道炎**：胃酸が食道に逆流し、炎症や不快感を引き起こす状態であり、制酸剤はその治療において重要な役割を果たします。 - **胃炎**：胃の内壁が炎症を起こし、痛みを伴うことがあるため、その緩和のために制酸剤が用いられます。 - **胃潰瘍**：潰瘍ができている場合、胃酸の刺激を和らげるために制酸剤が利用されることがあります。 また、制酸剤に関連する技術として、製剤技術や投与経路の研究が挙げられます。例えば、錠剤としてのみならず、液体やジェル状の製品、カプセル状の製品など多様な形態で提供されることで、患者が服用しやすくなる工夫がなされています。 最近では、制酸剤以外にもプロトンポンプインヒビター（PPI）やヒスタミンH2受容体拮抗薬などの新しい薬剤も胃酸に関連する病態の治療に用いられるようになってきました。これらの薬剤は、制酸剤と比較して長期的な使用においても効果を持ち続けることができる一方で、服用を中止した際に症状が悪化することがあるため、医療機関での指導が必要となります。 制酸剤の利用は多くの人々にとって重要な健康維持の一環ですが、自己判断での使用や長期にわたる服用は避けるべきであることを覚えておくべきです。症状が慢性化している場合や、一定期間以上にわたって使用する場合には、専門的な医療の助言を得ることが推奨されます。 最後に、日常生活においては、食事内容や食べ方、生活習慣等にも気を配ることが、制酸剤を必要としない健康的な消化器系を維持するためには重要です。過度なストレスや不規則な生活習慣が胃腸の健康に影響を及ぼすこともあるため、これら全般に配慮することが、長期的な健康維持につながるでしょう。 |